Franklin Biotechnology Discovery Fund Advisor Class (FTDZX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
116.32
+1.66 (1.45%)
May 19, 2025, 12:19 PM EDT
FTDZX Holdings List
As of Apr 30, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | VRTX | Vertex Pharmaceuticals Incorporated | 7.98% |
2 | GILD | Gilead Sciences, Inc. | 7.55% |
3 | AMGN | Amgen Inc. | 7.37% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.06% |
5 | ASND | Ascendis Pharma A/S | 4.89% |
6 | ARGX | argenx SE | 4.08% |
7 | JAZZ | Jazz Pharmaceuticals plc | 3.92% |
8 | MRUS | Merus N.V. | 3.21% |
9 | PTCT | PTC Therapeutics, Inc. | 3.10% |
10 | INFXX | Institutional Fiduciary Trust - Money Market Portfolio | 2.50% |
11 | LLY | Eli Lilly and Company | 2.48% |
12 | NBIX | Neurocrine Biosciences, Inc. | 2.43% |
13 | BNTC | Benitec Biopharma Inc. | 2.34% |
14 | INSM | Insmed Incorporated | 2.31% |
15 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.26% |
16 | GH | Guardant Health, Inc. | 2.16% |
17 | AZN | AstraZeneca PLC | 2.08% |
18 | ARQT | Arcutis Biotherapeutics, Inc. | 2.03% |
19 | QURE | uniQure N.V. | 1.45% |
20 | MIRM | Mirum Pharmaceuticals, Inc. | 1.32% |
21 | CNTA | Centessa Pharmaceuticals plc | 1.31% |
22 | MLYS | Mineralys Therapeutics, Inc. | 1.29% |
23 | SPRY | ARS Pharmaceuticals, Inc. | 1.29% |
24 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.08% |
25 | PCVX | Vaxcyte, Inc. | 1.06% |
26 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.00% |
27 | JBIO | Jade Biosciences, Inc. | 0.97% |
28 | DAWN | Day One Biopharmaceuticals, Inc. | 0.94% |
29 | SNDX | Syndax Pharmaceuticals, Inc. | 0.92% |
30 | JANX | Janux Therapeutics, Inc. | 0.87% |
31 | APGE | Apogee Therapeutics, Inc. | 0.86% |
32 | CGON | CG Oncology, Inc. | 0.80% |
33 | GPCR | Structure Therapeutics Inc. | 0.74% |
34 | SRPT | Sarepta Therapeutics, Inc. | 0.74% |
35 | BBIO | BridgeBio Pharma, Inc. | 0.73% |
36 | AVTR | Avantor, Inc. | 0.70% |
37 | CPH: ZEAL | Zealand Pharma A/S | 0.70% |
38 | AURA | Aura Biosciences, Inc. | 0.64% |
39 | NUVL | Nuvalent, Inc. | 0.61% |
40 | PRAX | Praxis Precision Medicines, Inc. | 0.60% |
41 | n/a | Benitec Biopharma ([Wts/Rts]) | 0.60% |
42 | SYRE | Spyre Therapeutics, Inc. | 0.59% |
43 | CGEM | Cullinan Therapeutics, Inc. | 0.57% |
44 | OLMA | Olema Pharmaceuticals, Inc. | 0.56% |
45 | TMO | Thermo Fisher Scientific Inc. | 0.52% |
46 | XENE | Xenon Pharmaceuticals Inc. | 0.50% |
47 | ABVX | ABIVAX Société Anonyme | 0.50% |
48 | OCUL | Ocular Therapeutix, Inc. | 0.48% |
49 | DYN | Dyne Therapeutics, Inc. | 0.48% |
50 | RARE | Ultragenyx Pharmaceutical Inc. | 0.45% |
51 | ANAB | AnaptysBio, Inc. | 0.40% |
52 | ORKA | Oruka Therapeutics, Inc. | 0.37% |
53 | COGT | Cogent Biosciences, Inc. | 0.35% |
54 | ETR: SRT3 | Sartorius Aktiengesellschaft | 0.34% |
55 | EPA: DIM | Sartorius Stedim Biotech S.A. | 0.34% |
56 | CTNM | Contineum Therapeutics, Inc. | 0.33% |
57 | ACHV | Achieve Life Sciences, Inc. | 0.33% |
58 | SION | Sionna Therapeutics, Inc. | 0.31% |
59 | AKBA | Akebia Therapeutics, Inc. | 0.30% |
60 | ORIC | ORIC Pharmaceuticals, Inc. | 0.29% |
61 | KURA | Kura Oncology, Inc. | 0.26% |
62 | NAMS | NewAmsterdam Pharma Company N.V. | 0.25% |
63 | CYTK | Cytokinetics, Incorporated | 0.25% |
64 | MBX | MBX Biosciences, Inc. | 0.24% |
65 | ENGN | enGene Holdings Inc. | 0.22% |
66 | SLDB | Solid Biosciences Inc. | 0.21% |
67 | HLVX | HilleVax, Inc. | 0.19% |
68 | n/a | Lycia Therapeutics Inc Prf Usd 0.0001 Ser C | 0.19% |
69 | CNTX | Context Therapeutics Inc. | 0.18% |
70 | n/a | Candid Therapeutics Inc Cnv Pfd Ser B | 0.18% |
71 | JSPR | Jasper Therapeutics, Inc. | 0.15% |
72 | ANRO | Alto Neuroscience, Inc. | 0.15% |
73 | ABOS | Acumen Pharmaceuticals, Inc. | 0.13% |
74 | SLNO | Soleno Therapeutics, Inc. | 0.10% |
75 | KYTX | Kyverna Therapeutics, Inc. | 0.08% |
76 | TSX: MSCL | Satellos Bioscience Inc. | 0.08% |
77 | ARTV | Artiva Biotherapeutics, Inc. | 0.07% |
78 | n/a | Carmot Therapeutics Inc Esrw Usd 1 | 0.06% |
79 | INAB | IN8bio, Inc. | 0.05% |
80 | ALEC | Alector, Inc. | 0.05% |
81 | CAMP | Camp4 Therapeutics Corporation | 0.05% |
82 | APLT | Applied Therapeutics, Inc. | 0.04% |
83 | n/a | Achieve Life Sciences Inc Wts Exp 08/31/2027 *Vault* | 0.03% |
84 | TERN | Terns Pharmaceuticals, Inc. | 0.01% |
85 | n/a | In8bio Inc Series C Wts Exp 10/04/2027 *Not In Bank* | 0.01% |
86 | NUVB.WS | Nuvation Bio ([Wts/Rts]) | 0.00% |
87 | n/a | Dkk | 0.00% |
88 | n/a | Sanofi Sa Esrw Usd Npv Ref Sm# 1134484 | 0.00% |
89 | n/a | Usd | -0.24% |
As of Apr 30, 2025